产业链观察2022-01-25 21:20
药闻| 2022年1月25日,美国ICER发布关于预防化疗诱导性中性粒细胞减少症的新药证据报告草案。
波士顿,2022年1月25日--临床和经济审查研究所(ICER)今天发布了一份证据报告草案,评估了普利那布($万春医药(BYSI)$ )和trilaciclib(Cosela™,$G1治疗(GTHX)$ )在预防化疗诱导的中性粒细胞...查看全文
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005656 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005657 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005660 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005658 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005659 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005655 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005605 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005606 Size: 5 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005608 Size: 9 KB 网页链接
$G1 Therapeutics(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-24-005607 Size: 9 KB 网页链接